The negative feedback loop of NF-κB/miR-376b/NFKBIZ in septic acute kidney injury

Zhiwen Liu1, Chengyuan Tang1, Liyu He1

  • 1Department of Nephrology and.

JCI Insight
|December 17, 2020
PubMed

Insights

MicroRNA-376b (miR-376b) decreases in septic acute kidney injury (AKI), impacting kidney cells and inflammation. Urinary miR-376b shows diagnostic potential for sepsis-induced AKI.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Sepsis is a primary cause of acute kidney injury (AKI), but its underlying mechanisms are not fully understood.
  • MicroRNAs (miRNAs) play critical roles in cellular processes and disease pathogenesis.

Purpose of the Study:

  • To investigate the role of microRNA-376b (miR-376b) in the pathogenesis of septic AKI.
  • To evaluate the diagnostic potential of urinary miR-376b in patients with sepsis-associated AKI.

Main Methods:

  • Assessed miR-376b levels in renal tubular cells and urine of mice with septic AKI.
  • Analyzed urinary miR-376b in human sepsis patients with and without AKI.
  • Investigated the regulatory pathway involving NF-κB, miR-376b, and NFKBIZ using cell culture and animal models.
  • Utilized Chromatin Immunoprecipitation (ChIP) and luciferase reporter assays.

Main Results:

  • miR-376b levels were significantly decreased in renal tubular cells and urine during septic AKI in mice.
  • Lower urinary miR-376b levels were observed in sepsis patients with AKI compared to those without AKI.
  • NF-κB activation by LPS reduced miR-376b expression, and NF-κB directly bound to the miR-376b promoter.
  • miR-376b exacerbated tubular injury and inflammation, while its inhibition was protective.
  • miR-376b directly targeted and suppressed NF-κB inhibitor ζ (NFKBIZ).

Conclusions:

  • A novel NF-κB/miR-376b/NFKBIZ negative feedback loop regulates kidney inflammation and tubular damage in septic AKI.
  • Urinary miR-376b serves as a potential diagnostic biomarker for AKI in sepsis patients.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.9K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
568
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
300
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
148
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
469
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
203